Kaiser Permanente

Irvine, California 92618

0 studies enrolling now · 3 studies all time

What they study most

Bacterial Infection, HER2-Positive Primary Breast Cancer, Leprosy, Residual Invasive Breast Cancer

Studies at this site

• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy — Completed
• Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy — NO_LONGER_AVAILABLE